Clinical Trials Browser

Pancreatic Neoplasms × simtuzumab × Gastrointestinal × Clear all

NCT01472198 2015-03-10

A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Phase 2 Completed

Gastrointestinal

Neoplasms, Pancreatic Neoplasms